Systolic pulmonary artery pressure (sPAP) is a well-known outcome predictor in patients with valvular heart disease. Limited data are available regarding the evaluation of right ventricular (RV) performance, particularly in patients with aortic stenosis (AS). The aim of this study was to evaluate the prevalence, determinants, and prognostic significance of RV dysfunction in severe AS independently from the strategy of treatment chosen.
Introduction
Right ventricular (RV) dysfunction is a well-known predictor of both morbidity and mortality in various cardiovascular (CV) diseases, including heart failure (HF), 1,2 myocardial infarction, 3 and primary pulmonary hypertension (PH). 4 In patients with valvular heart disease, PH-rather than RV dysfunction-has been traditionally considered a predictor of poor prognosis, particularly in mitral regurgitation (MR). 5, 6 Current European recommendations specify, in fact, that a systolic pulmonary artery pressure (sPAP) .50 mmHg at rest and an exercise sPAP .60 mmHg should be an indication for surgery (Classes IIa and IIb, respectively) in asymptomatic patients with severe primary MR. 7 Neglecting the evaluation of the RV as opposed to the left ventricle (LV) is due to that PH is considered the main determinant of RV dysfunction in left-sided heart diseases. 8 Although several studies have addressed the evaluation of sPAP in aortic stenosis (AS) patients, along with its impact on patient survival, 9, 10 scarce data are available regarding the prevalence and prognostic significance of RV dysfunction. 11 In spite of this, there is some evidence supporting a relationship between increased LV afterload and RV remodelling and dysfunction. 12, 13 Among several echocardiographic measures of RV function that have been proposed, tricuspid annular plane systolic excursion (TAPSE) is the one that has been more extensively studied. 14 -17 In patients with various CV diseases, a cut-off TAPSE of 17 mm was able to identify patients with RV dysfunction 15 and to predict poor prognosis. 18, 19 The present study sought therefore to assess the prevalence and prognostic impact of RV dysfunction, as assessed by TAPSE, in AS patients.
Methods
Between January 2012 and June 2013, 200 severe AS (aortic surface ,1 cm 2 or ,0.6 cm 2 /m 2 ) patients underwent standard transthoracic echocardiography for the evaluation of aortic valve gradients, LV and RV functions, as well as concomitant valvulopathies. Two-dimensional (2D) speckle tracking echocardiography was performed to assess LV global longitudinal strain (LV-GLS). Patients with suboptimal acoustic windows, cardiomyopathies (e.g. dilatative cardiomyopathy, alcoholic cardiomyopathy, cardiac amyloidosis etc.), and concomitant more than moderate valve disease were excluded from analysis. Clinical data including New York Heart Association (NYHA) class, age, gender, obesity, hypertension, hypercholesterolaemia, diabetes, coronary artery disease (CAD), and treatments were collected for each patient. The study protocol was approved by the local ethical committee, and all patients provided written consent prior to study participation.
Doppler echocardiography
All patients underwent standard transthoracic echocardiography using a Vivid 7 or Vivid 9 ultrasound system (GE Vingmed, Milwakee, WI, USA) equipped with a M5S 3.5-mHz transducer. M-mode, 2D, colour Doppler, pulsed-wave and continuous-wave Doppler data were stored onto a dedicated workstation for off-line analysis (EchoPAC, GE Healthcare, Horten, Norway). Severity of AS was assessed according to the current guidelines. 7, 20 Continuous-wave Doppler was used to measure aortic transvalvular velocities. Peak aortic gradient and mean aortic gradient (MAG) were measured using the modified Bernoulli equation. The aortic valve area (AVA) was calculated by means of the standard continuity equation. LV dimensions and mass were measured in accordance with the joined European Association of Echocardiography and American Society of Echocardiography guidelines. 21 LV function was obtained using the Simpson biplane method of discs from the apical four-and twochamber views. 21 Tissue Doppler imaging was used to detect lateral and septal mitral annulus velocities, which were averaged to obtain s ′ m velocity as a measure of global LV longitudinal function. 22 The ratio of early transmitral flow velocity to tissue Doppler imaging (TDI) annular velocity (E/e ′ ) was considered an index of mean LV filling pressure. 22 RV function was estimated by TAPSE, by placing an M-mode cursor through the lateral tricuspid annulus in a four-chamber view. The peak excursion of the tricuspid annulus was measured and the average value over 3 -5 heart beats was taken into account. 14 The maximal lateral tricuspid annulus velocity measured at TDI (s ′ tr ) was also used to evaluate RV performance, and a s ′ tr ≤9 cm/s defined RV dysfunction as recommended. 14 The sPAP was determined from the tricuspid regurgitation (TR) jet velocity using the modified Bernoulli equation, and this value was combined with an estimate of the right atrial pressure by means of the diameter and collapsibility of the inferior vena cava. 14 To calculate LV-GLS, 2D greyscale images were acquired in the standard apical four-, three-, and two-chamber views at a frame rate of at least 80 frames/s. During off-line analysis, a line was traced along the endocardium's inner border in each of the three apical views on an end-systolic frame, and a region of interest was automatically defined between the endocardial and epicardial borders, with GLS then automatically calculated from the strain in the three apical views.
Follow-up
Follow-up data were obtained by means of phone contacts with patients, their general practitioners, or their cardiologists. Particular care was taken to collect data pertaining to HF occurrences, hospitalization causes, and patient deaths. The clinical management of patients was determined independently by their personal physicians. The study's primary endpoint was CV mortality, and its secondary endpoint was major adverse cardiovascular events (MACEs). MACEs were defined as the first event occurring among HF, cardiac-related hospitalization, and overall mortality.
Statistical analysis
Data were expressed as mean + standard deviation for continuous variables and as percentages for categorical variables. Between-group comparisons were performed using Student's t-tests or x 2 test, as appropriate. To identify physiological correlates of RV function, univariate linear regression analysis was carried out. After excluding variables showing collinearity (Pearson's coefficient .0.6), all the variables that were significant at univariate analysis were entered into a stepwise multivariate regression analysis. Receiver operator characteristic (ROC) curves considering multiple dichotomies of TAPSE (14, 15, 16, 17 , and 18 mm) and s ′ tr (8, 9, 10, 11 , and 12 cm/s) were obtained. The relative areas under the curves (AUCs) were then compared to verify that our cut-off was appropriate for mortality outcomes. The cut-off having the higher AUC was then retained for survival analysis. Long-term cardiovascular survival rates were calculated by means of the Kaplan -Meier method. The log-rank test and Breslow's test were used to compare event rates. Univariate Cox regression analysis was applied to assess the prognostic value of various clinical and echocardiographic parameters with respect to the predefined endpoints. Multivariate Cox regression analysis was then performed (forward stepwise method, entry and removal value 0.05-0.10), providing that covariates were not too highly correlated (Spearman's coefficient ,0.6). Hazard ratios (HRs) were estimated after adjusting for other outcome predictors, and covariates were required to have a P-value of ,0.05 to enter in the final model. Statistical analysis was performed using SPSS Version 20.0 (Chicago, IL, USA).
Results

Patient population
All clinical and echocardiographic characteristics of our population are summarized in Table 1 .
RV function evaluation
RV dysfunction according to a TAPSE of ≤17 mm was observed in 48 patients (24%). RV dysfunction patients displayed a significant reduction in all LV function parameters, including LVEF, s ′ m , and LV-GLS, and exhibited more elevated sPAP values. No differences in AS severity were found between the two groups, but a low-flow/low-gradient AS pattern was more common in RV dysfunction patients ( Table 1) .
RV function correlates at univariate regression analysis are given in Table 2 .
, P , 0.0001), and indexed left atrial volume (LAV i ) (r ¼ 20.30, P ¼ 0.001) displayed the strongest correlation with TAPSE ( Figure 1) . Of note is that the correlation of sPAP with TAPSE was weak (r ¼ 20.27, P ¼ 0.01) when compared with other parameters ( Table 2 , upper panel). Two multivariate regression models were then performed, using alternatively LVEF and GLS as a measure of LV performance ( Table 2 , lower panels). In Model A, LVEF (r ¼ 0.18, P ¼ 0.02), MAG (r ¼ 0.25, P ¼ 0.002), and LAV i (r ¼ 20.17, P ¼ 0.04) were significantly correlated with TAPSE, whereas sPAP was not. In Model B, when LV-GLS was used to estimate LV function, sPAP remained associated with TAPSE (r ¼ 20.20, P ¼ 0.03), whereas MAG (r ¼ 0.23, P ¼ 0.01) and LV-GLS (r ¼ 20.29, P ¼ 0.001) exhibited the strongest correlation.
Follow-up
Follow-up data were available for all patients, median follow-up lasting 16 other tested values [AUC 0.60, confidence interval (CI) 0.42-0.72 and AUC 0.58, CI 0.42-0.72, respectively], and were therefore retained for survival analysis. At Kaplan-Meier analysis, RV dysfunction described either by a TAPSE of ≤17 mm or a s ′ tr of ≤9 cm/s was associated with a slightly elevated mortality (Figure 2A and B) . When considering LV and RV functions, patients with LVEF .50% had a longer survival regardless of normal or reduced TAPSE values (24.3 + 0.4 and 23.5 + 1.1 months, respectively, P ¼ NS), whereas the combination of RV and LV dysfunctions (LVEF ≤50% and TAPSE ≤17 mm) was associated with a dramatic decrease in survival time (19.7 + 1.7 months, P ¼ 0.02; Figure 3 ). Predictors of CV mortality and MACEs at univariate Cox regression analysis are given in Table 3 . After correcting for CAD, AVA, and sPAP, the combination of either a TAPSE of ≤17 mm and an LVEF of ≤50% or of a s ′ tr of ≤9 cm/s and an LVEF 
Discussion
To the best of our knowledge, no study has so far specifically addressed the evaluation of RV function in AS patients. In this study involving 200 severe AS outpatients, a TAPSE of ≤17 mm was used to define RV dysfunction. According to this cut-off, the prevalence of RV impairment in our population was 24%. LVEF, LV-GLS, and MAG had a good correlation with TAPSE, whereas the correlation between TAPSE and sPAP was weaker or absent. These results suggest that the ventricular interdependence might have a fundamental role to play in the pathophysiology of RV dysfunction in AS. Biventricular impairment was associated with increased CV mortality as well. Our results emphasize that, in AS, prognosis depends not only on stenosis severity and LVEF, but rather on the concomitant development of RV dysfunction. This supports the necessity of a routine RV assessment in AS patients.
Prevalence of RV dysfunction in severe AS
Numerous surveys have shown the negative prognostic impact of PH in MR patients. 6, 7 On the contrary, only few studies have been published, which show the negative prognostic impact of PH in AS. 9 -11 Following aortic valve replacement, a temporary reduction in sPAP has been observed, yet sPAP values were shown rise again 12 months after the intervention, 10 which suggests that irreversible alterations of RV function or pulmonary vascular bed might have occurred. 23 Our study is the first to show that RV dysfunction is rather common in AS, as it was detected in one quarter of the enrolled patients. RV performance was evaluated using 2D echocardiography, which is the referral technique for assessing the aetiology and type of valve disease, as well as global heart performance. Among the various methods used to assess RV function, we selected TAPSE owing to its feasibility, high reproducibility, and robust predictive power. 19 TAPSE values have been shown to correlated with radionuclide angiography 16 and have been validated against biplane Simpson RV ejection fraction and RV fractional area shortening. 17 A s ′ tr of ≤9 cm/s was used as a further index of RV dysfunction, and a reduced s ′ tr confirmed our data on the negative prognostic impact of RV dysfunction in AS. With respect to TAPSE, however, less normative data are available for s ′ tr , 14 and this is particularly true in the elderly 14, 24, 25 as in the case of degenerative AS.
Pathophysiological significance of RV dysfunction in AS
According to a traditional model, in the context of left-sided heart disease, the progressive LV remodelling results in an increased LV end-diastolic pressure that can be transmitted backwards, leading to left atrial dilatation and increased pulmonary post-capillary Right ventricular dysfunction in severe aortic stenosis pressure. In the final stage, RV dysfunction develops as a direct consequence of the increased sPAP. 8, 23 In our study, LVEF and LV-GLS were the main correlates of RV performance, whereas the association between sPAP and TAPSE was mild or absent ( Table 2) . sPAP values can be underestimated because of either the low quality of the TR continuous Doppler envelope, 14 or in the case of RV dysfunction, 26 thus reducing the strength of the relationship between TAPSE and sPAP. Despite this, in our study, sPAP measure was possible in 84% of cases. Moreover, patients with a reduced TAPSE had significantly higher sPAP values ( Table 1) , and the presence of a preserved RV function did not excluded PH, which suggests that sPAP was not the main determinant of RV performance in our cohort. These results partially mirror what already observed by Le Tourneau et al. in severe MR, 27 thereby supporting that ventricular interdependence might be the main explanation of RV dysfunction also in the case of increased LV afterload. 12, 13 The RV and LV are intimately attached through the interventricular septum, sharing common fibres that encircle both ventricles, and are constraint into the pericardial space, which justifies the functional interdependence observed between the two cardiac chambers. 28 In AS, the chronic elevation in LV afterload causes LV hypertrophy and fibrosis, leading to a progressive deterioration in LV longitudinal function and finally to a decrease in LVEF. The alteration in LV function might therefore be transmitted to the RV through the interventricular septum, as already observed in some experimental models of AS 29 as well as in HF with reduced 1 or preserved 2 LVEF. Interestingly, the positive effect of LV contraction on RV function was enhanced in left-sided pressure overload cases, 29 which explains the positive relationship between MAG and TAPSE observed in our survey, along with the higher prevalence of RV dysfunction among low-flow/low-gradient AS patients. The molecular mechanisms and the proximity effects of growth-stimulating signals like angiotensin I and catecholamines produced in the hypertrophied LV 28, 30 might conceivably account for RV remodelling and functional deterioration in AS. This hypothesis is supported by the evidence that a moderate increase in LV afterload, as observed in essential hypertension, was shown to be associated with RV free wall thickening and concentric remodelling detected at cardiac MRI 12 and with RV longitudinal function impairment. 13 Clinical significance of RV function evaluation in AS PH has been traditionally described as a crucial determinant of outcome in numerous heart diseases. In our study, RV dysfunction alone was responsible for a slight increase in CV mortality, whereas the combination of RV and LV dysfunction turned out to be a significant predictor of CV mortality, which has interesting clinical implications. At present, the management of AS patients is primarily based on the assessment of AS severity, LVEF, and symptom onset. 7 Nevertheless, as previously stated by Pibarot and Dumesnil, 31 deep alteration in the whole heart structure and function. 31 Our study emphasizes the crucial role of biventricular function evaluation in AS patients. The primary structural abnormalities at the LV level might, in fact, spread to the RV along the anatomical and functional ventricular continuum, thereby influencing the prognosis of AS patients.
Limitations
This is a retrospective study conducted on consecutive AS patients meeting the eligibility criteria. CAD patients were included in this survey, because CAD is the most common comorbidity in AS. 32 Patients with moderate MR were also included in our study. The prevalence of MR was slightly higher in case of RV dysfunction, potentially influencing RV function deterioration. 27 Despite this, moderate MR was associated with MACEs, but not with CV mortality at Cox analysis, thus supporting its influence on symptom onset and hospitalization more than on mortality. In our study, TAPSE and s ′ tr were used to estimate RV function. Although these methods are easy to perform in routine clinical practice and have been validated in large patient cohorts, 14 they derives the global RV performance from the simple displacement of the lateral tricuspid annulus during systole, such disregarding the contribution of the interventricular septum and RV outflow tract towards overall RV performance. Another limitation consisted in the short follow-up period, which probably accounted for the limited number of events recorded in this population. In our study, LV function, rather than sPAP, resulted the main determinants of RV performance. Although this finding may be explained by ventricular interdependence, our data refer to overall LV performance. Yet no relationship was found between LV hypertrophy and RV function, and no specific analysis was performed to describe regional LV function abnormalities (e.g. LV septal segments with respect to other ventricular segments). These limitations might also explain the low correlation coefficients we found between TAPSE and LV function parameters. Our results need to be confirmed in larger surveys, and the pathophysiological mechanisms we outlined should be corroborated by using more sensible methods of biventricular function estimation.
Conclusions
RV dysfunction according to TAPSE values is common in AS patients. The correlation between TAPSE and LV function parameters suggests that the RV -LV interdependence is a fundamental phenomenon in AS. Given that biventricular function impairment was a strong predictor of CV mortality in our population, we propose that RV function should be carefully looked for in AS patients. Further studies are needed to confirm the prognostic value of RV dysfunction in severe AS patients and investigate the RV reverse remodelling following AS treatment.
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